| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP&Pres, Periph Intervent | SVP&Pres, Periph Intervent
1 company
Mirviss Jeffrey B. is an EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2023 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 353 | $55.03 | $19,425.59 | -0.6% | +22.3% | +65.1% | |
| Aug 29, 2023 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 18,628 | $53.48 | $996,229.63 | -12.9% | +1.8% | +45.4% | |
| Apr 5, 2023 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 4,903 | $50.40 | $247,111.20 | -5.9% | +4.9% | +33.5% | |
| Mar 30, 2023 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 4,903 | $49.60 | $243,188.80 | -5.5% | +7.8% | +38.1% | |
| Feb 22, 2023 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 5,653 | $46.19 | $261,112.16 | -3.0% | +10.5% | +43.2% | |
| Feb 17, 2023 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 3,470 | $46.53 | $161,454.46 | -1.9% | +14.8% | +41.4% | |
| Jan 4, 2023 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 6,751 | $46.38 | $313,122.86 | -7.1% | +7.7% | +25.1% | |
| Dec 12, 2022 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 11,080 | $46.75 | $517,990.00 | -11.1% | +1.0% | +18.7% | |
| Dec 9, 2022 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 41,032 | $46.15 | $1,893,503.70 | -29.2% | +1.8% | +18.9% | |
| Apr 20, 2022 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 9,645 | $46.50 | $448,492.50 | -8.0% | -19.9% | +11.7% |